Adenomyomatosis of the gallbladder (AG) is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is a very common condition, affecting up to 10% of people in some populations. AG is often asymptomatic and is usually discovered incidentally during imaging for other issues. However, it can cause symptoms such as abdominal pain, nausea, and vomiting. In some cases, AG can lead to complications such as gallbladder cancer and cholecystitis. As such, it is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed. This article will provide an overview of AG, including its causes, diagnosis, and treatment.
Adenomyomatosis of the gallbladder is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is caused by a buildup of mucus, bile, and other substances in the gallbladder. This buildup leads to the formation of small nodules, which can range in size from a few millimeters to several centimeters. AG can affect one or both sides of the gallbladder, and it can also affect different parts of the organ.
The exact cause of AG is not known. However, there are several risk factors that can increase a person’s likelihood of developing the condition. These risk factors include obesity, diabetes, and a high-fat diet. In addition, certain medications, such as steroids, can also increase the risk of developing AG.
AG is usually diagnosed during imaging tests, such as an ultrasound or CT scan. During these tests, the doctor will be able to see the thickened and nodular walls of the gallbladder. In some cases, a biopsy may also be performed to confirm the diagnosis.
In most cases, AG does not require treatment. However, if the condition is causing symptoms, it may be necessary to treat the underlying cause. For example, if the patient is overweight, they may be advised to lose weight. If the patient is taking steroids, they may be advised to stop taking them. In some cases, surgery may be necessary. This is usually only recommended if the patient is experiencing severe symptoms or if there is a risk of complications. Surgery may involve removing the gallbladder, or it may involve removing the nodules.
Adenomyomatosis of the gallbladder is a common condition that can cause symptoms such as abdominal pain, nausea, and vomiting. It is usually asymptomatic and is usually discovered incidentally during imaging tests. In most cases, AG does not require treatment, but if the patient is experiencing severe symptoms or if there is a risk of complications, surgery may be necessary. It is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed.
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation